From: Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
Before vaccination (%; 95% CI)) | After vaccination (%; 95% CI)) | OR (95% CI)a | |
---|---|---|---|
Absence from school | 9.4 (4.2–14.6) | 4.6 (0.2–9.1) | 0.49 (0.16–1.48) |
Absence from sport | 8.6 (3.6–13.7) | 4.6 (0.2–9.1) | 0.55 (0.18–1.66) |
Absence from other activities | 0 (−0.4–0.4) | 0 (−0.5–0.5) | Did not converge |
Analgesic use | 24.5 (17.0–32.0) | 12.0 (5.4–18.6) | 0.43 (0.21–0.91) |
Care from parents/guardians | 0.7 (−1.1–2.5) | 0 (−0.5–0.5) | Did not converge |
Medical intervention | 3.6 (0.1–7.1) | 0 (−0.5–0.5) | Did not converge |